Epigenetic modifications as regulatory elements of autophagy in cancer

Cancer Letters

Volumn 360, Issue 2, 2015, Pages 106-113

  Sui, Xinbing ^a,b   Zhu, Jing ^a   Zhou, Jichun ^a   Wang, Xian ^a,b   Li, Da ^a,b   Han, Weidong ^a,b   Fang, Yong ^a,b   Pan, Hongming ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b Key Laboratory of Biotherapy of Zhejiang Province   (China)

Author keywords

Autophagy; Cancer; Histone; Methylation; Tumor suppressor genes

Indexed keywords

DNA; HISTONE; HISTONE DEACETYLASE; MICRORNA;

APOPTOSIS; AUTOPHAGY; CELL CYCLE; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DOWN REGULATION; EPIGENETICS; GENE SILENCING; GENETIC REGULATION; GENOMIC INSTABILITY; HISTONE MODIFICATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; CARCINOGENESIS; GENETICS; NEOPLASM; PATHOLOGY; REGULATORY SEQUENCE;

ANIMALS; AUTOPHAGY; CARCINOGENESIS; EPIGENOMICS; HUMANS; NEOPLASMS; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 84924903322     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.009     Document Type: Review

References (112)

1. Suvà M.L., Riggi N., Bernstein B.E. Epigenetic reprogramming in cancer. Science 2013, 339:1567-1570.
2. Suárez-Álvarez B., Baragaño Raneros A., Ortega F., López-Larrea C. Epigenetic modulation of the immune function: a potential target for tolerance. Epigenetics 2013, 8:694-702.
3. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol 2007, 8:931-937.
4. Sui X., Jin L., Huang X., Geng S., He C., Hu X. p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment. Autophagy 2011, 7:565-571.
5. Sui X., Chen R., Wang Z., Huang Z., Kong N., Zhang M., et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 2013, 4:e838.
6. Sui X., Kong N., Ye L., Han W., Zhou J., Zhang Q., et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett 2014, 344:174-179.
7. Janku F., McConkey D.J., Hong D.S., Kurzrock R. Autophagy as a target for anticancer therapy. Nat. Rev. Clin. Oncol 2011, 8:528-539.
8. Maycotte P., Thorburn A. Autophagy and cancer therapy. Cancer Biol. Ther 2011, 11:127-137.
9. Hu X., Sui X., Li L., Huang X., Rong R., Su X., et al. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J. Pathol 2013, 229:62-73.
10. Sui X., Wang D., Geng S., Zhou G., He C., Hu X. Methylated promoters of genes encoding protocadherins as a new cancer biomarker family. Mol. Biol. Rep 2012, 39:1105-1111.
11. Lee T.F., Zhai J., Meyers B.C. Conservation and divergence in eukaryotic DNA methylation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9027-9028.
12. Law J.A., Jacobsen S.E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet 2010, 11:204-220.
13. Jones P.A., Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001, 293:1068-1070.
14. Wong J.J., Hawkins N.J., Ward R.L. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007, 56:140-148.
15. Li N., Li X., Li S., Zhou S., Zhou Q. Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell. Biochem. Biophys. Res. Commun 2013, 439:187-190.
16. Xie B., Zhou J., Shu G., Liu D.C., Zhou J., Chen J., et al. Restoration of klotho gene expression induces apoptosis and autophagy in gastric cancer cells: tumor suppressive role of klotho in gastric cancer. Cancer Cell Int 2013, 13:18.
17. Delage B., Luong P., Maharaj L., O'Riain C., Syed N., Crook T., et al. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis. Cell Death Dis 2012, 3:e342.
18. Sutter B.M., Wu X., Laxman S., Tu B.P. Methionine inhibits autophagy and promotes growth by inducing the SAM-responsive methylation of PP2A. Cell 2013, 154:403-415.
19. Laxman S., Sutter B.M., Tu B.P. Methionine is a signal of amino acid sufficiency that inhibits autophagy through the methylation of PP2A. Autophagy 2014, 10:386-387.
20. Bai H., Inoue J., Kawano T., Inazawa J. A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers. Oncogene 2012, 31:4397-4408.
21. Li Z., Chen B., Wu Y., Jin F., Xia Y., Liu X. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer 2010, 10:98.
22. Dunwell T., Hesson L., Rauch T.A., Wang L., Clark R.E., Dallol A., et al. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Mol. Cancer 2010, 9:44.
23. Haruki S., Imoto I., Kozaki K., Matsui T., Kawachi H., Komatsu S., et al. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis 2010, 31:1027-1036.
24. Tsao C.M., Yan M.D., Shih Y.L., Yu P.N., Kuo C.C., Lin W.C., et al. SOX1functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatology 2012, 56:2277-2287.
25. Li S., Yang P., Tian E., Zhang H. Arginine methylation modulates autophagic degradation of PGL Granules in C. elegans. Mol. Cell 2013, 52:421-433.
26. Kim Y., Kim Y.S., Kim D.E., Lee J.S., Song J.H., Kim H.G., et al. BIX-01294 inducesautophagy-associated cell death via EHMT2/G9a dysfunction and intracellular reactive oxygen species production. Autophagy 2013, 9:2126-2139.
27. Schnekenburger M., Grandjenette C., Ghelfi J., Karius T., Foliguet B., Dicato M., et al. Sustained exposure to the DNA demethylating agent, 2'-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy. Biochem. Pharmacol 2011, 81:364-378.
28. Liu H., He Z., Simon H.U. Autophagy suppresses melanoma tumorigenesis by inducing senescence. Autophagy 2014, 10:372-373.
29. Mann D.A. Epigenetics in liver disease. Hepatology 2014, 60(4):1418-1425. Epub ahead of print.
30. Moresi V., Carrer M., Grueter C.E., Rifki O.F., Shelton J.M., Richardson J.A., et al. Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1649-1654.
31. Oh M., Choi I.K., Kwon H.J. Inhibition of histone deacetylase1 induces autophagy. Biochem. Biophys. Res. Commun 2008, 369:1179-1183.
32. Xie H.J., Noh J.H., Kim J.K., Jung K.H., Eun J.W., Bae H.J., et al. HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer. PLoS ONE 2012, 7:e34265.
33. Peixoto P., Castronovo V., Matheus N., Polese C., Peulen O., Gonzalez A., et al. HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death Differ 2012, 19:1239-1252.
34. Lee J.-Y., Koga H., Kawaguchi Y., Tang W., Wong E., Gao Y.-S., et al. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 2010, 29:969-980.
35. Lee J.Y., Yao T.P. Quality control autophagy: a joint effort of ubiquitin, protein deacetylase and actin cytoskeleton. Autophagy 2010, 6:555-557.
36. Lee J.H., Mahendran A., Yao Y., Ngo L., Venta-Perez G., Choy M.L., et al. Development of a histone deacetylase 6 inhibitor and its biological effects. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:15704-15709.
37. Lee J.Y., Nagano Y., Taylor J.P., Lim K.L., Yao T.P. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell Biol 2010, 189:671-679.
38. Oehme I., Linke J.P., Böck B.C., Milde T., Lodrini M., Hartenstein B., et al. Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E2592-E2601.
39. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3374-3379.
40. Ou X., Lee M.R., Huang X., Messina-Graham S., Broxmeyer H.E. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 2014, 32:1183-1194.
41. Hariharan N., Maejima Y., Nakae J., Paik J., Depinho R.A., Sadoshima J. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res 2010, 107:1470-1482.
42. Inoue T., Nakayama Y., Li Y., Matsumori H., Takahashi H., Kojima H., et al. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors. FEBS J. 2014, 281:2623-2637.
43. Zhao Y., Yang J., Liao W., Liu X., Zhang H., Wang S., et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol 2010, 12:665-675.
44. Takasaka N., Araya J., Hara H., Ito S., Kobayashi K., Kurita Y., et al. Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence. J. Immunol 2014, 192:958-968.
45. Lee I.H., Finkel T. Regulation of autophagy by the p300 acetyltransferase. J. Biol. Chem 2009, 284:6322-6328.
46. Sebti S., Prébois C., Pérez-Gracia E., Bauvy C., Desmots F., Pirot N., et al. BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:4115-4120.
47. Sebti S., Prébois C., Pérez-Gracia E., Bauvy C., Desmots F., Pirot N., et al. BAG6/BAT3 modulates autophagy by affecting EP300/p300 intracellular localization. Autophagy 2014, 10:1341-1342.
48. Lin S.Y., Li T.Y., Liu Q., Zhang C., Li X., Chen Y., et al. GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy. Science 2012, 336:477-481.
49. Yi C., Ma M., Ran L., Zheng J., Tong J., Zhu J., et al. Function and molecular mechanism of acetylation in autophagy regulation. Science 2012, 336:474-477.
50. Füllgrabe J., Lynch-Day M.A., Heldring N., Li W., Struijk R.B., Ma Q., et al. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy. Nature 2013, 500:468-471.
51. van Engeland M., Derks S., Smits K.M., Meijer G.A., Herman J.G. Colorectal cancer epigenetics: complex simplicity. J. Clin. Oncol 2011, 29:1382-1391.
52. Juengel E., Dauselt A., Makarević J., Wiesner C., Tsaur I., Bartsch G., et al. Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells. Cancer Lett 2012, 324:83-90.
53. Bedi U., Mishra V.K., Wasilewski D., Scheel C., Johnsen S.A. Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer. Oncotarget 2014, 5:2016-2029.
54. De Ruijter A., Van Gennip A., Caron H., Kemp S., van Kuilenburg A. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 2003, 370:737-749.
55. Li Z., Zhu W.G. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications. Int. J. Biol. Sci 2014, 10:757-770.
56. Marks P.A., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 2001, 1:194-202.
57. Robert T., Vanoli F., Chiolo I., Shubassi G., Bernstein K.A., Rothstein R., et al. HDACs link the DNA damage response, processing of double strand breaks and autophagy. Nature 2011, 471:74-79.
58. Shubassi G., Robert T., Vanoli F., Minucci S., Foiani M. Acetylation: a novel link between double-strand break repair and autophagy. Cancer Res 2012, 72:1332-1335.
59. Huang R., Xu Y., Wan W., Shou X., Qian J., You Z., et al. Deacetylation of nuclear LC3 drives autophagy initiation under starvation. Mol. Cell 2015, 57(3):456-466. pii: S1097-2765(14)00962-9.
60. Medema R.H., Jäättelä M. Cytosolic FoxO1: alive and killing. Nat. Cell Biol 2010, 12:642-643.
61. Zhao Y., Li X., Cai M.Y., Ma K., Yang J., Zhou J., et al. XBP-1u suppresses autophagy by promoting the degradation of FoxO1 in cancer cells. Cell Res 2013, 23:491-507.
62. Zhou J., Liao W., Yang J., Ma K., Li X., Wang Y., et al. FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway. Autophagy 2012, 8:1712-1723.
63. Artal-Martinez de Narvajas A., Gomez T.S., Zhang J.S., Mann A.O., Taoda Y., Gorman J.A., et al. Epigenetic regulation of autophagy by the methyltransferase G9a. Mol. Cell. Biol 2013, 33:3983-3993.
64. Collins P.L., Oltz E.M. Histone methylation keeps the brakes on autophagy. Mol. Cell. Biol 2013, 33:3974-3975.
65. Ke X.X., Zhang D., Zhu S., Xia Q., Xiang Z., Cui H. Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS ONE 2014, 9:e106962.
66. Sharma S., Mells J.E., Fu P.P., Saxena N.K., Anania F.A. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS ONE 2011, 6:e25269.
67. Cernotta N., Clocchiatti A., Florean C., Brancolini C. Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility. Mol. Biol. Cell 2011, 22:278-289.
68. Jia H., Kast R.J., Steffan J.S., Thomas E.A. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems. Hum. Mol. Genet 2012, 21:5280-5293.
69. Matsumoto G., Wada K., Okuno M., Kurosawa M., Nukina N. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol. Cell 2011, 44:279-289.
70. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol 2011, 13:132-141.
71. Iorio M.V., Croce C.M. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol 2009, 27:5848-5856.
72. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
73. Bi C., Chng W.J. MicroRNA: important player in the pathobiology of multiple myeloma. Biomed Res. Int 2014, 2014:521586.
74. Anwar S.L., Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J. Gastroenterol 2014, 20:7894-7913.
75. Huang Y., Chuang A.Y., Ratovitski E.A. Phospho-δNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure. Cell Cycle 2011, 10:3938-3947.
76. Zhu H., Wu H., Liu X., Li B., Chen Y., Ren X., et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009, 5:816-823.
77. Chang Y., Yan W., He X., Zhang L., Li C., Huang H., et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. Gastroenterology 2012, 143:177-187.
78. Korkmaz G., le Sage C., Tekirdag K.A., Agami R., Gozuacik D. miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. Autophagy 2012, 8:165-176.
79. Frankel L.B., Wen J., Lees M., Høyer-Hansen M., Farkas T., Krogh A., et al. microRNA-101 is a potent inhibitor of autophagy. EMBO J. 2011, 30:4628-4641.
80. Mikhaylova O., Stratton Y., Hall D., Kellner E., Ehmer B., Drew A.F., et al. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 2012, 21:532-546.
81. Kovaleva V., Mora R., Park Y.J., Plass C., Chiramel A.I., Bartenschlager R., et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res 2012, 72:1763-1772.
82. Yang J., Chen D., He Y., Meléndez A., Feng Z., Hong Q., et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age (Dordr.) 2013, 35:11-22.
83. Kiga K., Mimuro H., Suzuki M., Shinozaki-Ushiku A., Kobayashi T., Sanada T., et al. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat. Commun 2014, 5:4497.
84. Seol H.S., Akiyama Y., Shimada S., Lee H.J., Kim T.I., Chun S.M., et al. Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes. Cancer Lett 2014, 353:232-241.
85. Zhang P.P., Wang X.L., Zhao W., Qi B., Yang Q., Wan H.Y., et al. DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells. J. Biol. Chem 2014, 289:24724-24735.
86. Gao W., Gu Y., Li Z., Cai H., Peng Q., Tu M., et al. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma. Oncogene 2014, Epub ahead of print. 10.1038/onc.2014.101.
87. Bi H.C., Pan Y.Z., Qiu J.X., Krausz K.W., Li F., Johnson C.H., et al. N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis. Carcinogenesis 2014, 35:2264-2272.
88. Zhang E.B., Kong R., Yin D.D., You L.H., Sun M., Han L., et al. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget 2014, 5:2276-2292.
89. Ng H.Y., Wan T.S., So C.C., Chim C.S. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia. J. Clin. Pathol 2014, 67:626-631.
90. Feng L., Ma Y., Sun J., Shen Q., Liu L., Lu H., et al. YY1-MIR372-SQSTM1 regulatory axis in autophagy. Autophagy 2014, 10:1442-1453.
91. Roccaro A.M., Sacco A., Jia X., Azab A.K., Maiso P., Ngo H.T., et al. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood 2010, 116:1506-1514.
92. Kita Y., Vincent K., Natsugoe S., Berindan-Neagoe I., Calin G.A. Epigenetically regulated microRNAs and their prospect in cancer diagnosis. Expert Rev. Mol. Diagn 2014, 14:673-683.
93. Pirtoli L., Cevenini G., Tini P., Vannini M., Oliveri G., Marsili S., et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 2009, 5:930-936.
94. Cao J., Song Y., Bi N., Shen J., Liu W., Fan J., et al. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer Res 2013, 73:3326-3335.
95. Nihira K., Miki Y., Iida S., Narumi S., Ono K., Iwabuchi E., et al. An activation of LC3A-mediated autophagy contributes to de novo and acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma. J. Pathol 2014, 234:277-288.
96. Syed N., Langer J., Janczar K., Singh P., Lo Nigro C., Lattanzio L., et al. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma. Cell Death Dis 2013, 4:e458.
97. Oehme I., Lodrini M., Brady N.R., Witt O. Histone deacetylase 10-promoted autophagy as a druggable point of interference to improve the treatment response of advanced neuroblastomas. Autophagy 2013, 9:2163-2165.
98. Gammoh N., Marks P.A., Jiang X. Curbing autophagy and histone deacetylases to kill cancer cells. Autophagy 2012, 8:1521-1522.
99. Hrzenjak A., Kremser M.L., Strohmeier B., Moinfar F., Zatloukal K., Denk H. SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway. J. Pathol 2008, 216:495-504.
100. Chiao M.T., Cheng W.Y., Yang Y.C., Shen C.C., Ko J.L. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. Autophagy 2013, 9:1509-1526.
101. Lee Y.J., Won A.J., Lee J., Jung J.H., Yoon S., Lee B.M., et al. Molecular mechanism of SAHA on regulation of autophagic cell death in tamoxifen-resistant MCF-7 breast cancer cells. Int. J. Med. Sci 2012, 9:881-893.
102. Chen M.Y., Liao W.S., Lu Z., Bornmann W.G., Hennessey V., Washington M.N., et al. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer 2011, 117:4424-4438.
103. Liu Y.L., Yang P.M., Shun C.T., Wu M.S., Weng J.R., Chen C.C. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 2010, 6:1057-1065.
104. Wang J., Kim T.H., Ahn M.Y., Lee J., Jung J.H., Choi W.S., et al. Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells. Int. J. Oncol 2012, 41:1101-1109.
105. Ouyang D., Zhang Y., Xu L., Li J., Zha Q., He X. Histone deacetylase inhibitor valproic acid sensitizes B16F10 melanoma cells to cucurbitacin B treatment. Acta Biochim. Biophys. Sin. (Shanghai) 2011, 43:487-495.
106. Wang Z., Wang N., Liu P., Chen Q., Situ H., Xie T., et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget 2014, 5:7013-7026.
107. Sarkar S., Horn G., Moulton K., Oza A., Byler S., Kokolus S., et al. Cancer development, progression, and therapy: an epigenetic overview. Int. J. Mol. Sci 2013, 14:21087-21113.
108. Torgersen M.L., Engedal N., Bøe S.O., Hokland P., Simonsen A. Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells. Blood 2013, 22:2467-2476.
109. Füllgrabe J., Klionsky D.J., Joseph B. Histone post-translational modifications regulate autophagy flux and outcome. Autophagy 2013, 9:1621-1623.
110. Füllgrabe J., Klionsky D.J., Joseph B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat. Rev. Mol. Cell Biol 2014, 15:65-74.
111. Vasilatou D., Papageorgiou S.G., Dimitriadis G., Pappa V. Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes. Epigenetics 2013, 8:61-570.
112. Baer C., Claus R., Plass C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 2013, 73:473-477.